CIRANNI, Annamaria
 Distribuzione geografica
Continente #
NA - Nord America 847
EU - Europa 683
AS - Asia 224
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.757
Nazione #
US - Stati Uniti d'America 829
IE - Irlanda 197
SE - Svezia 191
CN - Cina 140
IT - Italia 80
SG - Singapore 61
DE - Germania 58
UA - Ucraina 42
GB - Regno Unito 29
BE - Belgio 28
FI - Finlandia 26
IN - India 14
MX - Messico 14
FR - Francia 10
CZ - Repubblica Ceca 9
CA - Canada 4
NL - Olanda 4
RU - Federazione Russa 4
AT - Austria 2
CL - Cile 2
ID - Indonesia 2
KR - Corea 2
VN - Vietnam 2
BG - Bulgaria 1
EU - Europa 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
LV - Lettonia 1
PL - Polonia 1
Totale 1.757
Città #
Dublin 197
Chandler 189
Nyköping 95
Jacksonville 88
Ashburn 69
Ann Arbor 64
Singapore 48
Beijing 45
Dearborn 35
Messina 32
Princeton 31
Medford 28
Brussels 24
Cambridge 23
Des Moines 21
Bremen 20
New York 15
Boardman 14
Munich 10
Nanjing 10
Brno 9
Guadalupe 9
Jinan 9
Shenyang 9
Tianjin 9
Wilmington 9
Hyderabad 8
Lancaster 8
Woodbridge 8
Palo Del Colle 7
Los Angeles 6
Ningbo 6
Rome 6
Zhengzhou 6
Ciudad Benito Juárez 5
Falls Church 5
Hangzhou 5
Hebei 5
Pune 5
Taizhou 5
Haikou 4
Waanrode 4
Anaheim 3
Fuzhou 3
Houston 3
Ottawa 3
San Jose 3
San Mateo 3
Seattle 3
Taiyuan 3
Washington 3
Augusta 2
Bari 2
Catanzaro 2
Città Sant'Angelo 2
Dong Ket 2
Hefei 2
Jakarta 2
Kunming 2
Namdong-gu 2
Northampton 2
Nuremberg 2
San Antonio 2
San Filippo 2
Vienna 2
Alba 1
Aliso Viejo 1
Auburn Hills 1
Birmingham 1
Bonavista 1
Changsha 1
Chengdu 1
Cisano Bergamasco 1
Cranford 1
Dalian 1
Espoo 1
Guangzhou 1
Helsinki 1
Hongtong 1
Hull 1
Hwang Chow 1
Klyuchik 1
Kraków 1
Mainz 1
Milan 1
Nanchang 1
Norwalk 1
Novokuznetsk 1
Phoenix 1
Porto Torres 1
Reston 1
Rochester 1
Santa Clara 1
Shijiazhuang 1
Sofia 1
Tappahannock 1
Tokyo 1
Totale 1.292
Nome #
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 86
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 84
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 74
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 73
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 72
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 69
Miopatie metaboliche 68
null 67
Studio dell'espressione genica del muscolo scheletrico in pazienti affetti da glicogenosi II 66
Pilot study of flavocoxid in ambulant DMD patients. 65
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 65
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 64
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 63
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 61
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 60
null 58
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 57
Calpain 3 deficiency in Quail Eater's disease 55
Telomere length modulation in astroglial brain tumors 54
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 52
Pilot study of flavocoxid in ambulant DMD patients. 49
Intracranial aneurysm management in patients with late-onset Pompe disease (LOPD) 45
null 42
Expression of the trascription factor NFkB in different muscular dystrophies 39
Nusinersen modulates proteomics profiles of cerebrospinal fluid in spinal muscular atrophy type 1 patients 39
Role of calcineurin/NFAT on muscle regeneration in dystrophic process. 38
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 36
Implication of SIRT1 and its downstream pathways in dystrophic process. 36
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 29
null 27
Pilot study of flavocoxid in ambulant DMD patients. 27
Tubular aggregates: do they help in diagnosing neuromuscular disorders ? 25
null 22
Pilot study of flavocoxid in ambulant DMD patients. 21
null 18
Totale 1.806
Categoria #
all - tutte 7.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020158 0 0 0 0 1 38 27 20 3 38 29 2
2020/2021211 18 0 44 14 43 11 7 11 5 38 11 9
2021/2022269 5 37 1 9 16 2 34 9 2 60 22 72
2022/2023632 45 73 31 52 58 53 8 52 238 2 18 2
2023/2024210 11 26 5 31 20 45 6 7 0 15 19 25
2024/2025109 32 4 15 45 13 0 0 0 0 0 0 0
Totale 1.806